GL1X · GenesisL1 explorer

MolNFT v1 · #148110 · protein

Crystal structure of rhodesain in complex with a macrolactam inhibitor

6EX8 · Cysteine protease: “Crystal structure of rhodesain in complex with a macrolactam inhibitor”. X-ray diffraction, 1 ligand (C2K), 5 pockets (best druggability 0.78). MolNFT v1 #148110 on GenesisL1: 3D structure, binding sites and…

PDB
6EX8
Type
protein
Length
434 residues
Chains
2
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Cysteine protease
UniProt
Q95PM0
Ligands
C2K
Pockets
5 · best druggability 0.78

Structure

x-ray diffraction · 1 distinct chain · 26% helix, 23% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
A, BCysteine proteaseprotein21726% helix, 23% strandQ95PM0

Ligands and binding sites

  • C2K · (3~{S})-~{N}-[1-(aminomethyl)cyclopropyl]-19-chloranyl-5-oxidanylidene-9-(trifluoromethyl)-12,17-dioxa-4-azatricyclo[16.2.2.0^{6,11}]docosa-1(20),6(11),7,9,18,21-hexaene-3-carboxamide · ligand · 2 copies · chains A, B
  • EDO · 1,2-ethanediol · additive · 17 copies · chains A, B

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

5 pockets found on a 1 Å grid, 1 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
14810.780.8560EDO
2940.330.7323empty
3650.330.7713empty
4610.330.7615empty
5520.280.7517empty

Interfaces

1 interface between chains.

  • A–B · 605 Ų buried · 2 hydrogen bonds · protein-protein

Modifications

Observed in the structure: 6 disulfide, 2 modified, 1 covalent (disulfide, oxidation, covalent ligand).

Compared structures

  • 6EX8 · Crystal Structure of Rhodesain in complex with a Macrolactam Inhibitor · the same entry in another collection · chain A against A, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.